Australia, Feb. 25 -- Renibus Therapeutics Inc., owns the trademark (2506347) for 'CYAXXVI' till June 5, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surger...